InMed Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
#1445-885 W Georgia St, Vancouver, Briti...Phone Number
(604) 669-7207Website
www.inmedpharma.comRevenue
<$5 MillionStock Symbol
INMIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About InMed Pharmaceuticals
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It operates through two segments: InMed Pharma and BayMedica Commercial. The InMed Pharma segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry.Explore more
InMed Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InMed Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on InMed Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when InMed Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at InMed Pharmaceuticals
Check out if InMed Pharmaceuticals is spiking on competitors!
InMed Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once InMed Pharmaceuticals has new funding data
Click to see if InMed Pharmaceuticals had a recent Job posting/layoffs
Check if InMed Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined InMed Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to InMed Pharmaceuticals
Compare insights from companies similar to InMed Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InMed Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
InMed Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about InMed Pharmaceuticals.
InMed Pharmaceuticals financials insights
Gather financial insights about InMed Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Stock/Share Issuance
$3.7M
InMed Pharmaceuticals Tech Stack
A closer look at the technologies used by InMed Pharmaceuticals
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Funding
Funding
Funding
Funding
Earnings
Financial Planning, Sales, Logistics / Supply Chain, Finance, Manufacturing Operations, Operations, Revenue Operations
Earnings
Project
Product Development, Product Management, Sales, Business Development, Clinical Operations, Operations
InMed Pharmaceuticals News & Media
InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript
InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call December 17, 2025 7:01 PM ESTCompany ParticipantsEric Adams - President, CEO &...Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors - Newsfile Corp.
Vancouver, British Columbia--(Newsfile Corp. - October 16, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical...InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors - Yahoo Finance
Vancouver, British Columbia--(Newsfile Corp. - October 9, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of Mr. Neil Klompas, CPA, CA to its Board of Directors, effective immediately.Mr. Klompas brings over 30 years of experience in healthcare and biotechnology across operational,...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding InMed Pharmaceuticals
Sign Up For FreeTo access detailed company insights
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It operates through two segments: InMed Pharma and BayMedica Commercial. The InMed Pharma segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops... Read More
